Diroximel fumarate in patients with relapsing–remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study

  1. Singer, B.A.
  2. Arnold, D.L.
  3. Drulovic, J.
  4. Freedman, M.S.
  5. Gold, R.
  6. Gudesblatt, M.
  7. Jasinska, E.
  8. LaGanke, C.C.
  9. Naismith, R.T.
  10. Negroski, D.
  11. Oh, J.
  12. Hernandez Perez, M.A.
  13. Selmaj, K.
  14. Then Bergh, F.
  15. Wundes, A.
  16. Ziemssen, T.
  17. Castro-Borrero, W.
  18. Chen, H.
  19. Levin, S.
  20. Scaramozza, M.
  21. Shankar, S.L.
  22. Wang, T.
  23. Wray, S.
Aldizkaria:
Multiple Sclerosis Journal

ISSN: 1477-0970,  1352-4585

Argitalpen urtea: 2023

Alea: 29

Zenbakia: 14

Orrialdeak: 1795-1807

Mota: Artikulua

DOI: 10.1177/13524585231205708 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus